HEINEMAN THOMAS CHARLES

PrivateCIK: 2103579
Location

SAN DIEGO, CA

HEINEMAN THOMAS CHARLES enters ONCOLYTICS BIOTECH INC with 270.69K shares plus derivative instruments

Holding both equity and derivatives at entry signals strong long-term conviction in the company.

Direct Derivatives
InsiderHEINEMAN THOMAS CHARLESCIK 2103579
→
IssuerONCOLYTICS BIOTECH INCCIK 1129928
Officer· Chief Medical Officer
Since Feb 2026
270.69K
Baseline shares
100% direct
270.69K
Direct ownership
1 position
1.58M
Derivative underlying
7 instruments
1
Security positions
All direct
Non-Derivative Holdings1

Common Shares

Direct
Shares owned270.69K
Total
270.69K direct270.69K
Derivative Holdings7

Stock Option

Direct
Underlying security
Common Shares

Underlying shares

88.90K

Shares owned

N/A

Exercise price

2.76

Expiration

—

Exercise window

—

Stock Option

Direct
Underlying security
Common Shares

Underlying shares

120K

Shares owned

N/A

Exercise price

3.40

Expiration

—

Exercise window

—

Stock Option

Direct
Underlying security
Common Shares

Underlying shares

231.70K

Shares owned

N/A

Exercise price

1.91

Expiration

—

Exercise window

—

Stock Option

Direct
Underlying security
Common Shares

Underlying shares

80K

Shares owned

N/A

Exercise price

2.31

Expiration

—

Exercise window

—

Stock Option

Direct
Underlying security
Common Shares

Underlying shares

570K

Shares owned

N/A

Exercise price

1.08

Expiration

—

Exercise window

—

Stock Option

Direct
Underlying security
Common Shares

Underlying shares

243.60K

Shares owned

N/A

Exercise price

1.13

Expiration

—

Exercise window

—

Stock Option

Direct
Underlying security
Common Shares

Underlying shares

250K

Shares owned

N/A

Exercise price

0.99

Expiration

—

Exercise window

—

Total

Underlying

1.58M

Owned

0.00

HEINEMAN THOMAS CHARLES — Initial Ownership Disclosure (Form 3) Filed Jan 2, 2026 | Finecho